New test can predict return of cancer

Apr 28, 2006

U.S. regulators have approved a test that reportedly can predict who are at high risk for a return of cancer after surgical removal of the prostate gland.

The test, known as Prostate PX, uses advanced computer technology and digital imaging to determine an individual's risk for a recurrence of cancer, reports The Washington Times.

The test, produced by Aureon Laboratories of Yonkers, N.Y., has been approved by the U.S. Food and Drug Administration and is being marketed around the country, the report said.

"Prostate cancer is the most diagnosed cancer in U.S. men, with about 230,000 diagnoses yearly. Of those, 90,000 to 100,000 men undergo a prostatectomy, or surgical removal of the prostate," said Rob Shovlyn with Aureon Laboratories.

The Times reported about 15 percent of post-prostatectomy patients experience a return of cancer. But, until now, it has been difficult for doctors to identify patients who fall into this high-risk category.

Copyright 2006 by United Press International

Explore further: Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer

Related Stories

VCs bet big on Silicon Valley biotech

May 28, 2015

Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.

Recommended for you

Asian-language smoking quitline successful nationwide

1 hour ago

(HealthDay)—An Asian-Language Smokers Quitline (ASQ) reaches Chinese, Korean, and Vietnamese speakers nationwide, and most callers receive medication and counseling, according to a study published online ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.